Enzo Biochem (ENZ) Reports Q4 EPS of $0.77

Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $0.77, versus $0.18 reported last year. Revenue for the quarter came in at $26.6 million, versus $25.7 million reported last year.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform